Tenaris Announces 2014 Second Quarter Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Tenaris Announces 2014 Second Quarter Results

LUXEMBOURG--(Marketwired - Jul 30, 2014) - Tenaris S.A. ( NYSE : TS ) ( BAE : TS ) ( BMV : TS ) ( MILAN : TEN ) ("Tenaris") today announced its results for the quarter ended June 30, 2014 in comparison with its results for the quarter ended June 30, 2013.

Summary of 2014 Second Quarter Results

(Comparison with first quarter of 2014 and second quarter of 2013)

             
    Q2 2014   Q1 2014   Q2 2013
Net sales ($ million)   2,661   2,580   3%   2,829   (6%)
Operating income ($ million)   549   566   (3%)   578   (5%)
Net income ($ million)   420   428   (2%)   430   (2%)
Shareholders' net income ($ million)   408   423   (3%)   418   (2%)
Earnings per ADS ($)   0.69   0.72   (3%)   0.71   (2%)
Earnings per share ($)   0.35   0.36   (3%)   0.35   (2%)
EBITDA * ($ million)   702   718   (2%)   730   (4%)
EBITDA margin (% of net sales)   26.4%   27.8%       25.8%    
                     
                     

*EBITDA is defined as operating income plus depreciation, amortization and impairment charges/(reversals)

Our second quarter sales increased 3% sequentially and included a record level of sales in Sub-Saharan Africa which offset the usual seasonal effect in Canada. Our EBITDA and operating margins continued to benefit from a favorable product mix.

Cash flow from operations amounted to $566 million during the second quarter of 2014. Following a dividend payment of $354 million in May 2014, and capital expenditures of $223 million during the quarter, we maintained a net cash position (cash and other current investments less total borrowings) of $1.3 billion at the end of the quarter.

Market Background and Outlook

In the United States, drilling activity has gradually increased in the first half. Higher oil production is boosting operator cash flows which is expected to drive further expansion. The duties on OCTG imports from nine countries, including South Korea, determined by the U.S. Department of Commerce, if confirmed by the U.S. International Trade Commission in its injury ruling expected in August, should provide some relief to domestic OCTG manufacturers and result in increased sales and a more favorable pricing environment. Elsewhere in North America, we expect drilling activity and sales in Mexico to recover slowly in the second half while drilling activity and sales in Canada should be above last year's levels.

In the rest of the world, drilling activity continues to show a gradual increase in many regions, led by gas drilling in the Middle East and deepwater drilling in sub-Saharan Africa. However, our sales and product mix in the second half will be affected by inventory adjustments in Saudi Arabia and a continuing low level of sales in Brazil. Sales in the third quarter will be additionally affected by lower shipments to sub-Saharan Africa following the record level of this quarter.

Considering these effects, we confirm our expectation that our overall results for 2014 will be in line with those for 2013, with a decline in the third quarter followed by a recovery in the fourth.

Analysis of 2014 Second Quarter Results

             
Tubes Sales volume (thousand metric tons)   Q2 2014   Q1 2014   Q2 2013
Seamless   703   669   5%   677   4%
Welded   199   241   (17%)   286   (30%)
Total   902   910   (1%)   963   (6%)
                     
                     
             
Tubes   Q2 2014   Q1 2014   Q2 2013
(Net sales - $ million)                    
North America   1,069   1,085   (1%)   986   8%
South America   454   440   3%   652   (30%)
Europe   263   256   3%   218   21%
Middle East & Africa   560   536   4%   626   (11%)
Far East & Oceania   101   101   -   137   (26%)
Total net sales ($ million)   2,447   2,418   1%   2,619   (7%)
Operating income ($ million)   538   561   (4%)   553   (3%)
Operating income (% of sales)   22.0%   23.2%       21.1%    
                     
                     

Net sales of tubular products and services increased 1% sequentially but declined 7% year on year. Sales increased sequentially driven by record sales in Sub-Saharan Africa, which offset the spring breakup effect in Canada. In North America sales declined due to the seasonal spring break up in Canada, partially offset by increased sales in Mexico. In South America, sales increased due to higher sales of OCTG in Argentina. In Europe, higher sales of OCTG more than offset lower sales of line pipe products. In the Middle East and Africa sales increased due to record level of shipments to Sub-Saharan Africa deepwater projects, partially offset by lower sales in the Middle East. In the Far East and Oceania, sales remained stable. The 7% year on year decline in sales was mostly due to lower shipments in Brazil.

Operating income from tubular products and services decreased 4% sequentially and 3% year on year. Sequentially, the decrease in operating income was mainly due to higher SG&A expenses.

             
Others   Q2 2014   Q1 2014   Q2 2013
Net sales ($ million)   214   162   32%   210   2%
Operating income ($ million)   12   4   200%   26   (54%)
Operating income (% of sales)   5.6%   2.8%       12.2%    
                     
                     

Net sales of other products and services increased 32% sequentially, mainly due to higher sales of sucker rods, industrial equipment in Brazil and pipes for electric conduit in the USA. Sequentially, the operating margin increased following the increase in sales and a recovery in operating margins.

Selling, general and administrative expenses , or SG&A, amounted to $518 million, or 19.5% of net sales, in the second quarter of 2014, compared to $489 million, 18.9% in the previous quarter and $529 million, 18.7% in the second quarter of 2013. The sequential increase was mainly due to higher service and logistics costs.

Financial results in the second quarter of 2014 amounted to zero, compared to a gain of $42 million in the previous quarter and a loss of $11 million in the second quarter of 2013. The gain in the previous quarter was mainly related to a 22.3% Argentine peso devaluation in the first quarter of 2014.

Equity in earnings of associated companies generated a gain of $14 million in the second quarter of 2014, compared to a gain of $19 million in the previous quarter and a gain of $12 million in the second quarter of last year. These results are mainly derived from our equity investment in Ternium ( NYSE : TX ).

Income tax charges totaled $144 million in the second quarter of 2014, equivalent to 26.2% of income before equity in earnings of associated companies and income tax, compared to $199 million, or 32.7% in the previous quarter and $150 million or 26.4% in the second quarter of 2013.

Results attributable to non-controlling interests amounted to gains of $12 million in the second quarter of 2014, compared to $6 million in the previous quarter and $12 million in the second quarter of 2013. These results are mainly attributable to NKKTubes, our Japanese subsidiary.

Cash Flow and Liquidity of 2014 Second Quarter

Net cash provided by operations during the second quarter of 2014 was $566 million, compared to $612 million in the previous quarter and $607 million in the second quarter of 2013.

Capital expenditures amounted to $223 million for the second quarter of 2014, compared to $189 million in the previous quarter and $180 million in the second quarter of 2013. The increase has to do with the progress in the construction of the greenfield seamless facility in Bay City, Texas.

Following a dividend payment of $354 million in May 2014, our financial position at June 30, 2014, amounted to a net cash position (cash and other current investments less total borrowings) of $1.3 billion, a similar level to that of the previous quarter.

Analysis of 2014 First Half Results

             
    H1 2014   H1 2013   Increase/(Decrease)
Net sales ($ million)   5,241   5,508   (5%)
Operating income ($ million)   1,115   1,132   (1%)
Net income ($ million)   848   852   (1%)
Shareholders' net income ($ million)   830   843   (1%)
Earnings per ADS ($)   1.41   1.43   (1%)
Earnings per share ($)   0.70   0.71   (1%)
EBITDA ($ million)   1,421   1,429   (1%)
EBITDA margin (% of net sales)   27.1%   25.9%    
             
             

Our sales in the first half of 2014 declined 5% compared to the first half of 2013, mainly due to lower shipments of welded pipes in Brazil. EBITDA declined 1% to $1,421 million in the first half of 2014 compared to $1,429 million in the first half of the previous year, as an improvement in margins, driven by a better mix of products sold, partially offset the decline in sales.

Cash flow from operations amounted to $1,178 million during the first half of 2014. Following a dividend payment of $354 million in May 2014, and capital expenditures of $412 million during the first half of 2014, we reached a net cash position (cash and other current investments less total borrowings) of $1.3 billion at the end of June 2014.

The following table shows our net sales by business segment for the periods indicated below:

             
Net sales ($ million)   H1 2014   H1 2013   Increase/(Decrease)
Tubes   4,865   93%   5,107   93%   (5%)
Others   376   7%   400   7%   (6%)
Total   5,241   100%   5,508   100%   (5%)
                     
                     

Tubes The following table indicates, for our Tubes business segment, sales volumes of seamless and welded pipes for the periods indicated below:

             
Sales volume (thousand metric tons)   H1 2014   H1 2013   Increase/(Decrease)
Seamless   1,372   1,334   3%
Welded   440   576   (24%)
Total   1,812   1,910   (5%)
             
             

The following table indicates, for our Tubes business segment, net sales by geographic region, operating income and operating income as a percentage of net sales for the periods indicated below:

             
Tubes   H1 2014   H1 2013   Increase/(Decrease)
(Net sales - $ million)            
North America   2,154   2,129   1%
South America   894   1,247   (28%)
Europe   519   486   7%
Middle East & Africa   1,096   1,026   7%
Far East & Oceania   202   219   (8%)
Total net sales ($ million)   4,865   5,107   (5%)
Operating income ($ million)   1,099   1,079   2%
Operating income (% of sales)   22.6%   21.1%    
             
             

Net sales of tubular products and services decreased 5% to $4,865 million in the first half of 2014, compared to $5,107 million in the first half of 2013, as a result of flat average selling prices and lower shipments of welded pipes in Brazil.

Operating income from tubular products and services increased 2% to $1,099 million in the first half of 2014, from $1,079 million in the first half of 2013. Despite a 5% decrease in net sales, operating income increased due to an improvement in the operating margin, mainly due to a better mix of products sold.

Others The following table indicates, for our Others business segment, net sales, operating income and operating income as a percentage of net sales for the periods indicated below:

             
Others   H1 2014   H1 2013   Increase/(Decrease)
Net sales ($ million)   376   400   (6%)
Operating income ($ million)   16   53   (70%)
Operating income (% of sales)   4.3%   13.3%    
             
             

Net sales of other products and services decreased 6% to $376 million in the first half of 2014, compared to $400 million in the first half of 2013, mainly due to lower sales of industrial equipment in Brazil.

Operating income from other products and services decreased 70%, to $16 million in the first half of 2014, compared to $53 million during the first half of 2013, due to a 6% decline in sales and a lower operating margin.

Selling, general and administrative expenses, or SG&A, amounted to $1,007 million in the first half of 2014 and $1,005 million in the first half of 2013, however, it increased as a percentage of net sales to 19.2% in the first half of 2014 compared to 18.2% in the first half of 2013 mainly due to the effect of fixed and semi fixed expenses on lower sales.

Financial results amounted to a gain of $43 million in the first half of 2014, compared to a loss of $20 million in the first half of 2013. Net interest expenses amounted to $5 million in the first half of 2014, compared to $18 million in the first half of 2013. The decrease in interest expenses was due to an increase in our net cash position. In addition, in the first half of 2014 we had positive other financial results amounting to $48 million, mainly due to the positive impact from the Argentine peso devaluation against the U.S. dollar on our Argentine peso-denominated borrowings and liabilities.

Equity in earnings of associated companies generated a gain of $33 million in the first half of 2014, compared to a gain of $24 million in the first half of 2013. These results are mainly derived from our equity investment in Ternium ( NYSE : TX ) and Usiminas (BSP: USIM). 

Income tax charges amounted to $343 million in the first half of 2014, equivalent to 29.6% of income before equity in earnings of associated companies and income tax, compared to $284 million in the first half of 2013, or 25.5% of income before equity in earnings of associated companies and income tax. During the first half of 2014, the tax rate was negatively affected by the effect of the Argentine peso devaluation on the tax base used to calculate deferred taxes.

Income attributable to non-controlling interests amounted to $18 million in the first half of 2014, compared to $10 million in the first half of 2013. These results are mainly attributable to NKKTubes, our Japanese subsidiary.

Cash Flow and Liquidity of 2014 First Half

Net cash provided by operations during the first half of 2014 amounted to $1,178 million, compared to $1,163 million in the first half of 2013.

Capital expenditures amounted to $412 million in the first half of 2014, compared to $364 million in the first half of 2013. The increase has to do mainly with the progress in the construction of the greenfield seamless facility in Bay City, Texas.

Following a dividend payment of $354 million in May 2014, our financial position at June 30, 2014, amounted to a net cash position (i.e., cash and other current investments less total borrowings) of $1.3 billion, compared with a net cash position of $214 million at June 30, 2013.

Tenaris Files Half-Year Report

Tenaris S.A. announces that it has filed its half-year report for the six-month period ended June 30, 2014 with the Luxembourg Stock Exchange. The half-year report can be downloaded from the Luxembourg Stock Exchange's website at www.bourse.lu and from Tenaris's website at www.tenaris.com/investors .

Holders of Tenaris's shares and ADSs, and any other interested parties, may request a hard copy of the half-year report, free of charge, at 1-888-300-5432 (toll free from the United States) or 52-229-989-1940 (from outside the United States).

Conference call

Tenaris will hold a conference call to discuss the above reported results, on July 31, 2014, at 9:00 a.m. (Eastern Time). Following a brief summary, the conference call will be opened to questions. To access the conference call dial in +1 866 383.8009 within North America or +1 617 597.5342 Internationally. The access number is "62522706". Please dial in 10 minutes before the scheduled start time. The conference call will be also available by webcast at www.tenaris.com/investors .

A replay of the conference call will be available on our webpage http://ir.tenaris.com/ or by phone from 1:00 pm on July 31 through 12:00 am on August 7. To access the replay by phone, please dial +1 888 286.8010 or +1 617 801.6888 and enter passcode "86199147" when prompted.

Some of the statements contained in this press release are "forward-looking statements." Forward-looking statements are based on management's current views and assumptions and involve known and unknown risks that could cause actual results, performance or events to differ materially from those expressed or implied by those statements. These risks include but are not limited to risks arising from uncertainties as to future oil and gas prices and their impact on investment programs by oil and gas companies.

   
Consolidated Condensed Interim Income Statement  
   
(all amounts in thousands of U.S. dollars)   Three-month period ended June 30,     Six-month period ended June 30,  
    2014     2013     2014     2013  
Continuing operations   Unaudited     Unaudited  
Net sales   2,660,882     2,829,270     5,240,826     5,507,575  
Cost of sales   (1,590,888 )   (1,714,443 )   (3,117,922 )   (3,359,875 )
Gross profit   1,069,994     1,114,827     2,122,904     2,147,700  
Selling, general and administrative expenses   (518,237 )   (529,329 )   (1,007,097 )   (1,004,894 )
Other operating income (expense) net   (2,475 )   (7,302 )   (755 )   (11,025 )
Operating income   549,282     578,196     1,115,052     1,131,781  
Interest income   9,944     6,870     19,006     12,951  
Interest expense   (10,618 )   (16,620 )   (23,621 )   (30,529 )
Other financial results   1,144     (955 )   47,578     (2,336 )
Income before equity in earnings of associated companies and income tax   549,752     567,491     1,158,015     1,111,867  
Equity in earnings of associated companies   14,367     11,869     33,188     24,066  
Income before income tax   564,119     579,360     1,191,203     1,135,933  
Income tax   (144,219 )   (149,795 )   (343,284 )   (283,651 )
Income for the period   419,900     429,565     847,919     852,282  
                         
                         
Attributable to:                        
Owners of the parent   407,885     417,828     830,390     842,605  
Non-controlling interests   12,015     11,737     17,529     9,677  
    419,900     429,565     847,919     852,282  
                         
                         
 
Consolidated Condensed Interim Statement of Financial Position
 
(all amounts in thousands of U.S. dollars)   At June 30, 2014   At December 31, 2013
    Unaudited    
ASSETS                
Non-current assets                
  Property, plant and equipment, net   4,856,796       4,673,767    
  Intangible assets, net   2,993,696       3,067,236    
  Investments in associated companies   941,501       912,758    
  Other investments   1,813       2,498    
  Deferred tax assets   219,560       197,159    
  Receivables   219,824   9,233,190   152,080   9,005,498
                 
Current assets                
  Inventories   2,774,035       2,702,647    
  Receivables and prepayments   232,688       220,224    
  Current tax assets   163,340       156,191    
  Trade receivables   1,962,412       1,982,979    
  Available for sale assets   21,572       21,572    
  Other investments   1,727,405       1,227,330    
  Cash and cash equivalents   642,382   7,523,834   614,529   6,925,472
Total assets       16,757,024       15,930,970
                 
EQUITY                
Capital and reserves attributable to owners of the parent       12,793,540       12,290,420
Non-controlling interests       148,483       179,446
Total equity       12,942,023       12,469,866
                 
LIABILITIES                
Non-current liabilities                
  Borrowings   173,083       246,218    
  Deferred tax liabilities   710,151       751,105    
  Other liabilities   284,168       277,257    
  Provisions   72,653   1,240,055   66,795   1,341,375
                 
                 
Current liabilities                
  Borrowings   913,125       684,717    
  Current tax liabilities   318,334       266,760    
  Other liabilities   342,022       250,997    
  Provisions   28,835       25,715    
  Customer advances   92,041       56,911    
  Trade payables   880,589   2,574,946   834,629   2,119,729
Total liabilities       3,815,001       3,461,104
Total equity and liabilities       16,757,024       15,930,970
                 
                 
   
Consolidated Condensed Interim Statement of Cash Flows  
   
    Three-month period ended June 30,     Six-month period ended June 30,  
(all amounts in thousands of U.S. dollars)   2014     2013     2014     2013  
    Unaudited     Unaudited  
Cash flows from operating activities                  
Income for the period   419,900     429,565     847,919     852,282  
Adjustments for:                        
Depreciation and amortization   153,079     151,602     305,743     296,972  
Income tax accruals less payments   (12,379 )   9,808     58,411     25,021  
Equity in earnings of associated companies   (14,367 )   (11,869 )   (33,188 )   (24,066 )
Interest accruals less payments, net   (9,957 )   (4,296 )   (18,056 )   (35,021 )
Changes in provisions   4,054     (4,051 )   8,978     (917 )
Changes in working capital   16,702     56,136     33,362     72,457  
Other, including currency translation adjustment   9,454     (19,853 )   (24,839 )   (24,021 )
Net cash provided by operating activities   566,486     607,042     1,178,330     1,162,707  
                         
Cash flows from investing activities                        
Capital expenditures   (223,177 )   (179,674 )   (412,222 )   (363,559 )
Advance to suppliers of property, plant and equipment   3,802     4,012     (24,849 )   11,758  
Investment in associated companies   -     -     (1,380 )   -  
Loan to associated companies   (9,900 )   -     (28,648 )   -  
Proceeds from disposal of property, plant and equipment and intangible assets   2,579     2,360     6,606     6,746  
Dividends received from associated companies   17,429     14,931     17,429     16,127  
Changes in investments in short terms securities   (195,629 )   (310,074 )   (500,075 )   (468,656 )
Net cash used in investing activities   (404,896 )   (468,445 )   (943,139 )   (797,584 )
                         
                         
Cash flows from financing activities                        
Dividends paid   (354,161 )   (354,161 )   (354,161 )   (354,161 )
Dividends paid to non-controlling interest in subsidiaries   (400 )   (1,858 )   (48,289 )   (18,529 )
Acquisitions of non-controlling interests   (50 )   (7,230 )   (140 )   (7,768 )
Proceeds from borrowings   712,807     594,658     1,207,214     1,220,390  
Repayments of borrowings   (531,530 )   (677,727 )   (1,000,200 )   (1,354,772 )
Net cash used in financing activities   (173,334 )   (446,318 )   (195,576 )   (514,840 )
                         
(Decrease) Increase in cash and cash equivalents   (11,744 )   (307,721 )   39,615     (149,717 )
                         
Movement in cash and cash equivalents                        
At the beginning of the period   649,689     925,554     598,145     772,656  
Effect of exchange rate changes   1,879     (11,807 )   2,064     (16,913 )
(Decrease) Increase in cash and cash equivalents   (11,744 )   (307,721 )   39,615     (149,717 )
At June 30,   639,824     606,026     639,824     606,026  
                         
    At June 30,     At June 30,  
    2014     2013     2014     2013  
Cash and cash equivalents                  
Cash and bank deposits   642,382     618,435     642,382     618,435  
Bank overdrafts   (2,558 )   (12,409 )   (2,558 )   (12,409 )
    639,824     606,026     639,824     606,026  
                         
                         

Giovanni Sardagna Tenaris 1-888-300-5432 www.tenaris.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 280

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 102

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 70

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 256

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 158

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 127

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading

Top 5 Most Recently Viewed Articles

What Your $1000 Investment in ASML Could Be Worth Now

Updated Category News Views 269

Exploring ASML Holding's Remarkable Growth ASML Holding (NASDAQ: ASML) has established itself as a leader in the semiconductor industry, offering substantial growth for investors. Over the past 15 years, the stock has consistently outperformed the market, delivering an impressive annualized return of 23.78%. This performance exceeds the overall market's growth by 11.35%,...

Continue Reading
Nvidia and Adobe Lead Stock Movement Trends This Week

Updated Category News Views 87

Significant Stock Movements in Today's Market Today's trading session has brought notable activity in the stock market, particularly among mega-cap and large-cap companies. With significant price fluctuations and market activity, investors are closely analyzing trends influenced by various factors, such as earnings reports and market sentiment. Mega-Cap Market Movers When...

Continue Reading
Charlotte's Web Unveils Innovative Quiet Sleep Mushroom Gummies

Updated Category News Views 184

Charlotte's Web Launches Quiet Sleep Mushroom Gummies A recent survey highlights that 43% of Americans struggle with sleep due to racing thoughts. To address this common issue, Charlotte's Web Holdings, Inc. introduces a natural remedy in the form of Quiet Sleep Mushroom Gummies. These gummies are melatonin-free and free from CBD, utilizing the calming properties of...

Continue Reading
Brown Brothers Harriman Expands Team with New Senior Wealth Planner

Updated Category News Views 258

Brown Brothers Harriman Enhances Wealth Planning Services Brown Brothers Harriman & Co. (BBH) has taken a significant step in strengthening its Chicago presence by welcoming Kristina White as a Senior Wealth Planner. With years of experience as a Managing Director and Partner at McDermott Will & Emery, Kristina brings a wealth of expertise in sophisticated wealth...

Continue Reading
Hospitality Sector Innovates to Overcome Market Challenges

Updated Category News Views 78

Hospitality Sector Innovates to Tackle Market Challenges In recent years, hospitality stocks have contended with major obstacles, including economic uncertainties and shifts in global markets. Despite these challenges, this industry has shown remarkable resilience, continually adapting and innovating to thrive amid adversity. As Wall Street watches for economic changes,...

Continue Reading